|
At the completion of the investigation, based on the information clinical evaluation was able to find substantial evidence to support the following reported events; endoleak type v.Due to limited medical information available, clinical was unable to find evidence to support the reported secondary procedure.Additionally there was evidence to reasonably support the following observation; endoleak type ii of the lumbar, suboptimal juxtarenal position of the suprarenal stent resulting in stenosis of the right renal ositium, without radiographic signs of blood flow insufficiency, and without evidence of renal atrophy.Cumulative knowledge informed by past assessments of similar complaints was applied to a review of the available medical information.The mostly likely cause of the loss of seal could not be determined.However, there was a non device related type ii endoleak, and patent lumbar arteries present post implant (anatomy related, cautionary product use condition) changed the sac composition and caused a non critical loss of overlap without evidence of a leak.Patent lumbar arteries most likely caused or contributed to this event.There was no user, or procedure- related issue detected.There were no off-label conditions detected.Associated clinical harms included: type ii endoleak; type v endoleak; and, a secondary endovascular intervention.The final patient status was reported as doing well post repair.Incidentally, there was a stenosis of the right renal artery caused by the fabric portion of the suprarenal cuff seen at one month post implant.It was unclear if there was stent movement/migration (intra or post operatively) verses user error at implant.Currently, this suboptimal cuff position has not deterred blood flow to the kidney; there were no signs of infarction/atrophy.Devices remain implanted in the patient and were not returned, no evaluation completed.The review of manufacturing lot confirmed all devices met specifications prior to release.This complaint is not capa eligible at this time.These types of events will be monitored and trended as part of the quality system.Correction: (b)(4).
|